Home › Funds › CAUSEWAY CAPITAL MANAGEMENT LLC › ZBH
CAUSEWAY CAPITAL MANAGEMENT LLC position in ZBH
ZIMMER BIOMET HOLDINGS INC · Health Care
CAUSEWAY CAPITAL MANAGEMENT LLC reported holding 412,776 shares of ZBH (ZIMMER BIOMET HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$36.7M, representing 0.41% of its reported portfolio and ranking #45 among its reported holdings. CAUSEWAY CAPITAL MANAGEMENT LLC has disclosed ZBH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CAUSEWAY CAPITAL MANAGEMENT LLC's ZBH position evolved
CAUSEWAY CAPITAL MANAGEMENT LLC first disclosed a stake in ZBH in Q3 2023 at 405,863 shares (US$45.5M). The position peaked in Q1 2025 at 805,509 shares, worth US$91.2M. Across 13 filings, CAUSEWAY CAPITAL MANAGEMENT LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 412,776 shares valued at US$36.7M — a reduction of -376,034 shares quarter over quarter.. Notable position changes include a 39% increase in Q4 2023 (shares rose 8% over the following quarter), a 31% increase in Q2 2024 (shares were roughly flat over the following quarter), a 48% trim in Q3 2026 (shares rose 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 405.86K | $45.55M | New |
| Q4 2023 | 564.67K | $68.72M | Add |
| Q1 2024 | 506.25K | $66.85M | Reduce |
| Q2 2024 | 660.81K | $71.72M | Add |
| Q3 2024 | 794.29K | $85.74M | Add |
| Q4 2024 | 769.93K | $81.33M | Reduce |
| Q1 2025 | 805.51K | $91.17M | Add |
| Q2 2025 | 578.24K | $52.74M | Reduce |
| Q3 2025 | 581.78K | $57.31M | Add |
| Q4 2025 | 728.50K | $65.51M | Add |
| Q1 2026 | 808.11K | $73.07M | Add |
| Q2 2026 | 788.81K | $67.91M | Reduce |
| Q3 2026 | 412.78K | $36.67M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZBH and 13F data
ZBH (ZIMMER BIOMET HOLDINGS INC) is a Health Care company. 18 other funds we track also report a position in ZBH — the largest reported positions include Dodge & Cox (US$2.08B), DODGE & COX (US$2.08B), Harris Associates (Oakmark) (US$1.10B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZBH
- Dodge & Cox 24.12M sh · $2.08B · Q2 2026
- DODGE & COX 24.12M sh · $2.08B · Q2 2026
- Harris Associates (Oakmark) 12.74M sh · $1.10B · Q2 2026
- HARRIS ASSOCIATES L P 12.74M sh · $1.10B · Q2 2026
More on CAUSEWAY CAPITAL MANAGEMENT LLC
FAQ
How long has CAUSEWAY CAPITAL MANAGEMENT LLC held ZBH?
CAUSEWAY CAPITAL MANAGEMENT LLC has disclosed ZBH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is CAUSEWAY CAPITAL MANAGEMENT LLC's current position in ZBH?
As of Q3 2026, CAUSEWAY CAPITAL MANAGEMENT LLC holds 412.78K shares of ZBH (ZIMMER BIOMET HOLDINGS INC), valued at $36.67M, representing 0.41% of its reported portfolio and ranking #45.
Has CAUSEWAY CAPITAL MANAGEMENT LLC been buying or selling ZBH?
In the latest 13F filing (Q3 2026), CAUSEWAY CAPITAL MANAGEMENT LLC reduced its position in ZBH. The position peaked in Q1 2025 at 805.51K shares.
Which other funds hold ZBH?
Other major institutional holders of ZBH include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.